References
- 1. Hunziker EB. Articular cartilage repair: are the intrinsic biological constraints undermining this process insuperable?. Osteoarthritis Cartilage. 1999; 7:15-28.10.1053/joca.1998.0159
- 2. Abramson SB, Yazici Y. Biologics in development for rheumatoid arthritis: Relevance to osteoarthritis. Adv Drug Deliv Rev. 2006; 58:212-25.10.1016/j.addr.2006.01.008
- 3. Hui W, Rowan A D, Cawston T. Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin1alpha. Ann Rheum Dis. 2001; 60:254-61.10.1136/ard.60.3.254
- 4. Kevorkian L, Young DA, Darrah CS, Donell T, Shepstone L, Porter S, et al. Expression Profiling of Metalloproteinases and Their Inhibitors in Cartilage. Arthritis Rheum. 2004; 50:131-41.10.1002/art.11433
- 5. Kozaci LD, Buttle DJ, Hollander AP. Degradation of type II collagen, but not proteoglycan, correlated with matrix metalloproteinase activity in cartilage explant cultures. Arthritis Rheum. 1997; 40:164-74.10.1002/art.1780400121
- 6. Takaishi H, Kimura T, Dalal S, Okada Y, D’Armiento J. Joint diseases and matrix metalloproteinases: A role for MMP-13. Curr Pharm Biotechnol. 2008; 9:47-54.10.2174/138920108783497659
- 7. Shingleton WD, Ellis AJ, Rowan AD, Cawston TE. Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: Matrix metalloproteinases-1 and -13 are involved in cartilage collagen breakdown. J Cell Biochem. 2000; 79:519-31. 10.1002/1097-4644(20001215)79:4<519::AID-JCB10>3.0.CO;2-U
- 8. Kozaci LD, Oktay G, Hollander AP. Effects of interleukin 1(IL1)-induced matrix breakdown on chondrocyte morphology in bovine nasal cartilage explants. Turk J Vet Anim Sci. 2005; 29:951-7.
- 9. Yeh LA, Augustine AJ, Lee P, Riviere LR, Sheldon A. Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants. J Rheumatol. 1995; 22:1740-6.
- 10. Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegard D, van den Berg WB. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen induced arthritis. Arthritis Res. 1999; 1:81-91.10.1186/ar14
- 11. Cleaver CS, Rowan AD, Cawston TE. Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines. Ann Rheum Dis. 2001; 60:150-7.10.1136/ard.60.2.150
- 12. Lacraz S, Nicod L, Galve-de Rochemonteix BG. B, Baumberger C, Dayer JM. Suppression of metalloproteinase biosynthesis human alveolar macrophages by interleukin-4. J Clin Invest. 1992; 90: 382-8.10.1172/JCI115872
- 13. Chowdhury TT, Bader DL, Lee DA . Anti-inflammatory effects of IL-4 and dynamic compression in IL-1beta stimulated chondrocytes. Biochem Biophys Res Commun. 2006; 339:241-7.10.1016/j.bbrc.2005.11.016
- 14. Augustine AJ, Oleksyszyn J. Glucocorticosteroids inhibit degradation in bovine cartilage explants stimulated with concomitant plasminogen and interleukin-1alpha. Inflamm Res. 1997; 46:60-4.10.1007/s000110050073
- 15. Ibanez M, Ortiz AM, Castrejon I, Garcia-Vadillo A, Carvajal I, Castaneda S, et al. A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass.in patients with early arthritis has a minimal impact on bone mass. Arthritis Res Ther. 2010; 12:R50.10.1186/ar2961
- 16. Shohani B, Orazizadeh M, Hashemitabar M, Heinegard D. Degradation of extracellular matrix molecules in interleukin-1treated bovine nasal cartilage. Iran Biomed J. 2010; 14:158-63.
- 17. Weyermann J, Lochmann D, Zimmer A. A practical note on the use of cytotoxicity assays. Int J Pharm. 2005; 288:369-76.10.1016/j.ijpharm.2004.09.018
- 18. Karsdal M A, Madsen SH, Christiansen C, Henriksen K, Fosang A J, Sondergaard B C. Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity. Arthritis Res Ther. 2008;10:R63.10.1186/ar2434
- 19. Laemmli UK. Cleavage of structure proteins during the assembly of the head of bacteriophage-T4. Nature. 1970; 227:680-5.10.1038/227680a0
- 20. Dickinson SC, Vankemmelbeke MN, Buttle DJ, Rosenberg K, Heinegard D, Hollander AP. Cleavage of cartilage oligomeric matrix protein (thrombospondin- 5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospond in motifs. Matrix Biol. 2003; 22:267-78.10.1016/S0945-053X(03)00034-9
- 21. Pattoli MA, MacMaster JF, Gregor KR, Burke JR. Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expression. J Pharmacol Exp Ther. 2005; 315:382-8.10.1124/jpet.105.087569
- 22. Nemoto O, Yamada H, Kikuchi T, Shinmei M, Obata K, Sato H, Seiki M. Suppression of matrix metalloproteinase-3 synthesis by interleukin-4 in human articular chondrocytes. J Rheumatol. 1997; 24: 1774-9.
- 23. Van de Loo FA, Arntz OJ, Enckevort FH, van Lent PL, van den Berg WB. Reduced cartilage proteoglycan loss during zymosan induced gonarthritis in NOS-2 deficient mice and in anti-interleukin-1 treated wild type mice with unabated joint inflammation. Arthritis Rheum. 1998; 41:634-46.10.1002/1529-0131(199804)41:4<634::AID-ART10>3.0.CO;2-1
- 24. Shimizu A, Watanabe S, Iimoto S, Yamamoto H. Interleukin-4 protects matrix synthesis in chondrocytes under excessive mechanical stress in vitro. Modern Rheumatol. 2004; 14:296-300.10.3109/s10165-004-0312-7
- 25. Arsenis C, McDonnell J. Effects of antirheumatic drugs on the interleukin-1alpha induced synthesis and activation of proteinases in articular cartilage explants in culture. Agents Actions.1989; 27:261-4.10.1007/BF019727912678951
- 26. Kamekura S, Hoshi K, Shimoaka T, Chung U, Chikuda H, Yamada T, et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage. 2005; 13: 632-41.10.1016/j.joca.2005.03.00415896985
- 27. Milner JM, Rowan AD, Cawston TE, Young DA. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis. Arthritis Res Ther. 2006; 8:R142.10.1186/ar2034177943116919164
- 28. Barmina OA, Walling HW, Fiacco GJ, Frije JM, Lopez-Otin C, Jeffrey JJ, et al. Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization. J Biol Chem. 1999; 274:30087-93.10.1074/jbc.274.42.3008710514495
- 29. Richardson DW, Dodge GR. Dose-dependent effects of corticosteroids on the expression of matrix related genes in normal and cytokine-treated articular chondrocytes. Inflamm Res. 2003; 52:39-49.10.1007/s00011030001212608648